Effects of olmesartan medoxomil as an angiotensin II-receptor blocker in chronic hypoxic rats

European Journal of Pharmacology

Volumn 528, Issue 1-3, 2005, Pages 43-51

  Nakamoto, Takaaki ^a   Harasawa, Hiroshi ^a   Akimoto, Kazumi ^a   Hirata, Hisato ^a   Kaneko, Hiromichi ^a   Kaneko, Noboru ^a   Sorimachi, Kenji ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II receptor blocker; Brain natriuretic peptide; Collagen; Hypoxia; Hypoxic cor pulmonale; Olmesartan medoxomil; Remodeling; TGF

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; OLMESARTAN; TRANSFORMING GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COR PULMONALE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; ECHOCARDIOGRAPHY; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE;

ADMINISTRATION, ORAL; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANOXIA; ANTIHYPERTENSIVE AGENTS; COLLAGEN; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ENDOTHELINS; HEART; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; IMIDAZOLES; LUNG; MALE; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PULMONARY ARTERY; PULMONARY HEART DISEASE; RATS; RATS, WISTAR; RNA, MESSENGER; TETRAZOLES; TRANSFORMING GROWTH FACTOR BETA;

EID: 28844465827     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.10.063     Document Type: Article

References (34)

1. A.J. Baertschi, and W.G. Teague Alveolar hypoxia is a powerful stimulus for ANP release in conscious lambs Am. J. Physiol. 256 1989 H990 H998
2. G.C. Blobe, W.P. Schiemann, and H.F. Lodish Role of transforming growth factor-β in human disease N. Engl. J. Med. 342 2000 1350 1358
3. F.C. Blumberg, K. Wolf, P. Sander, C. Lorenz, G.A.J. Riegger, and M. Pfeifer The NO donor molsidomine reduces endothelin-1 gene expression in chronic hypoxic rat lungs Am. J. Physiol., Lung Cell. Mol. Physiol. 280 2001 L258 L263
4. H.R. Brunner, and P. Laeis Clinical efficacy of olmesartan medoxomil J. Hypertens., Suppl. 2 2003 S43 S46 (Suppl.)
5. M.C. Chapell, P.E. Gallagher, D.B. Averill, C.M. Ferrario, and K.B. Brosnihan Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2.Lewis rat Hypertension 42 2003 781 786
6. P. Chomezynski, and N. Sacchi Single-step method of RNA isolation by acid guanidium thiocyanate phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
7. E.C. Cruch, W.C. Parks, J.L. Rosenbaum, D. Chamg, L. Whitehouse, L.J. Wu, K.R. Stenmark, E.C. Orton, and R.P. Mecham Regulation of collagen production by medial smooth muscle cells in hypoxic pulmonary hypertension Am. Rev. Respir. Dis. 140 1989 1045 1051
8. M.O. Farber, S.S.O. Kiblawi, R.A. Strawbridge, G.L. Robertson, and M.H. Weinberger Studies on plasma vasopressin and the renin-angiotensin-aldosterone system in chronic obstructive lung disease J. Lab. Clin. Med. 90 1977 373 380
9. N.O. Fowler, R.C. Westcott, and E. Hess The cardiac output in chronic cor pulmonale Circulation 6 1952 888 890
10. N.S. Hill, J.R. Klinger, R.R. Warburton, L. Pieras, and D.S. Wrenn Brain natriuretic peptide: possible role in the modulation of hypoxic pulmonary hypertension Am. J. Physiol. 266 1994 L308 L315
11. H.J. Hong, P. Chan, J.C. Liu, S.-H. Juan, M.-T. Huang, and T.-H. Cheng Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells Cardiovasc. Res. 61 2004 159 168
12. Y. Ishida, K. Tomori, H. Nakamoto, H. Imai, and H. Suzuki Effects of antihypertensive drugs on peritoneal vessels in hypertensive dogs with mild renal insufficiency Adv. Perit. Dial. 19 2003 10 14
13. D.D. Ivy Echocardiographic evaluation of pulmonary hypertension M.V. Lilliam O.C. Raul Echocardiographic Evaluation of Congenital Heart Disease 1999 Lippincott Raven Philadelphia 537 547
14. D.G. Kiely, R.I. Cargill, N.M. Wheeldon, W.J. Coutie, and B.J. Lipworth Haemodynamic and endocrine effects of type I angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale Cardiovasc. Res. 33 1997 201 208
15. J.R. Klinger, R.R. Warbuton, L. Pietras, and N.S. Hill Brain natriuretic peptide inhibits hypoxic pulmonary hypertension in rats J. Appl. Physiol. 84 1998 1646 1652
16. H.H. Leuchte, C. Neurohr, R. Baumgartner, M. Holzapfel, I.W. Giehr, M. Vogeser, and J. Behr Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension Am. J. Respir. Med. 170 1967 360 365
17. B.E. Levine, B.D. Bigelow, R.D. Homstra, H.J. Bekwitt, R.S. Mitchell, L.M. Nett, T.A. Stepenn, and T.L. Petty The role of long term continuous oxygen administration in patients with chronic airway obstruction with hypozaemia Am. Intern. Med. 66 1967 639 650
18. Y. Mitani, K. Maruyama, and M. Sakurai Prolonged administration of l-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats Circulation 96 1997 689 697
19. N. Nagaya, T. Nishikimi, Y. Okano, M. Uematsu, T. Satoh, S. Kyotani, S. Kuribayashi, S. Hamada, M. Kakishita, N. Nakanishi, M. Takamiya, T. Kunieda, H. Matsuo, and K. Kanmgawa Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension J. Am. Coll. Cardiol. 31 1988 202 208
20. D. O'Callaghan, and S.P. Gaine Bosentan: a novel agent for the treatment of pulmonary arterial hypertension Int. J. Clin. Pract. 58 2004 69 73
21. N.G. Perez, M.C. Villa-Abrille, E.A. Aiello, R.A. Dulce, H.E. Cingolani, and M.C. Camilion De Hurtado A low dose of angitotensinII increase inotropism through activation of reverse Na(+)/Ca(2+) exchange by endothelin release Cardiovasc. Res. 60 2003 589 597
22. M. Pfeifer, K. Wolf, F.C. Blumberg, D. Elsner, F. Muders, S.R. Holmer, G.A.J. Riegger, and A. Kurtz ANP gene expression in rat hearts during hypoxia Eur. J. Physiol. 434 1997 63 69
23. T.C. Resta, L.G. Chicoine, J.L. Omdahl, and B.R. Walker Maintained upregulation of pulmonary eNOS gene and protein expression during recovery from chronic hypoxia Am. J. Physiol. 276 1999 H699 H708
24. S. Sarkar, E. Vellaichamy, D. Young, and S. Sen Influence of cytokines and growth factors in AngII-mediated collagen upregulation by fibroblasts in rats: role of myocytes Am. J. Physiol. Heart Circ. Physiol. 287 1999 H107 H117
25. S. Soma, H. Takahashi, M. Muramatsu, M. Oka, and Y. Fukuchi Localization and distribution of endothelin receptor subtypes in pulmonary vascular of normal and hypoxia-exposed rats Am. J. Respir. Cell Mol. Biol. 20 1999 620 630
26. The Medical Research Council Working Party Long term domiciliary oxygen therapy in chronic hypoxic pulmonale complicating chronic bronchitis and emphysema Lancet 1 8222 1981 681 686
27. J.M. Tikkanen, P.K. Koskinen, and K.B. Lemstrom Role of endogenous endothelin-1 in transplant obliterative airway disease in the rat Am. J. Transplant. 4 2004 713 720
28. R.M. Timms, F.U. Khaja, and G.W. Williams Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease Ann. Intern. Med. 102 1985 29 36
29. M. Tóth, K.H. Vourinen, O. Vuolteenaha, I.E. Hassinen, P.A. Uusimaa, J. Leppäluoto, and H. Ruskoaho Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium Am. J. Physiol. 266 1994 H1572 H1580
30. M. Ueno, T. Miyachi, S. Sakai, R. Yayauchi-Kohno, K. Goto, and I. Yamaguchi A combination of oral endothelin-A receptor antagonist and oral prostacyclin analogue is superior to each drug alone in ameliorating pulmonary hypertension in rats J. Am. Coll. Cardiol. 40 2002 175 181
31. N.F. Voelkel, R.M. Tuder, J. Rridges, and W.P. Arend Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline Am. J. Respir. Cell Mol. Biol. 11 1994 664 675
32. P.L. Weissberg, C. Witchell, A.P. Davenport, T.R. Hesketh, and J.C. Metcalfe The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells Atherosclerosis 85 1990 257 262
33. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki A novel potent vasoconstriction peptide produced by vascular endothelial cells Nature 332 1988 411 415
34. R.M. Zakheim, L. Mattioli, A. Molteni, K.B. Mullis, and J. Bartley Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I converting enzyme in the rat Lab. Invest. 33 1975 57 61